Role of FDG-PET/CT in Assessment of Response to Therapy in Breast Cancer Patients

Role of 18 Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Assessment of Neoadjuvant Chemotherapy Response in Breast Cancer Patients

Role of fluorodeoxyglucose (FDG)-positron emission tomography (PET)- computed tomography (CT) in evaluation of post-treatment response of breast cancer

Role of 18FDG-PET/CT in evaluation of breast cancer metastasis

Role of 18F- FDG-PET/CT in Restaging of Breast Cancer Patients with High Tumour Markers and Equivocal Radiological Imaging

18FDG-PET/CT versus Contrast Enhanced CT in Detection of Loco-Regional Breast Cancer Recurrence.

Role of 18F FDG-PET/CT in Recurrent Breast Cancer: Correlation with CA15.3 and Survival Outcomes.

The Diagnostic Value of PET/CT in Breast Cancer Recurrence and Metastases

The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients

Role of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in evaluation of newly diagnosed breast cancer patients